Eliquis 5 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FTNS9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $45,937
Award facts
- Contract value 100% obligated
- $45,937.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60 units, with a ceiling value of $45,937.48. This is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The contract is scheduled for ultimate completion by June 3, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 comprehensive pharmaceutical support vehicle valued through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio with the DLA demonstrates its capability to fulfill competitive procurement requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical supplies. The Eliquis tablets supplied under this delivery order support military healthcare needs through DLA's Medical Supply Chain network, reinforcing AmerisourceBergen's role as a primary pharmaceutical supplier for federal defense and veteran health systems.
Quick answers
Who was awarded contract SPE2DB25FTNS9?
SPE2DB25FTNS9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 2, 2025.
How much is contract SPE2DB25FTNS9 worth?
The government has obligated $45,937 on SPE2DB25FTNS9.
Is contract SPE2DB25FTNS9 an order under another contract?
Yes. SPE2DB25FTNS9 is a delivery order under SPE2DB22D1103, an indefinite delivery contract.
Was contract SPE2DB25FTNS9 competed?
The extent of competition for SPE2DB25FTNS9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award